Conference Coverage

ADCs show early promise in NSCLC

“ADCs are a new, rapidly evolving class of therapeutics, and I think that we will all have to be prepared for the future that is coming,” said Dr...

Latest News

New COVID vaccines force bivalents out

The updated mRNA vaccines for 2023-2024 are being revised to include a single component that corresponds to the Omicron variant XBB.1.5.